LMP-2

LMP-2

Either of two transmembrane proteins—LMP-2A and LMP-2B—which are associated with Epstein-Barr virus, and block tyrosine kinase signalling by inhibiting viral lysis.
References in periodicals archive ?
Hodgkin lymphoma and nasopharyngeal carcinoma represent 2 major entities of type II malignancies, the pattern of which is characterized by the expression of EBERs, EBNA 1, LMP-1, and LMP-2. Epstein-Barr virus-associated malignancies expressing the full complement of latency antigens (EBNAs and LMPs) are classified as latency III malignancies and are only seen in immunocompromised individuals.